Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

Director Behbahani Ali sold $229,172 worth of Ordinary Shares with a nominal value of 0.001 GBP per share (19,500,000 units at $0.01) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.